Advertisement

Präkanzerosen aus dermatologischer Sicht

  • O. P. Hornstein
Conference paper
Part of the Verhandlungen der Deutschen Dermatologischen Gesellschaft book series (VDGDERMATOLOGIE, volume 33)

Zusammenfassung

Die Haut als das flächenhafte Grenz- und Kontaktorgan des Individuums zu seiner gesamten „Umwelt“ ist für die Erkennung und Erforschung von Präkanzerosen prädestiniert, da die makro- und mikroskopische Direktuntersuchung der Läsionen und ihrer Umgebung wesentliche Aufschlüsse über die Voraussetzungen, Bedingungen und Erscheinungsformen prämalignen Wachstums ermöglicht. Dieses Primat der Klinik, gleichwohl auch experimentelle Zusatzmodelle benötigend, verdeutlicht den Rang der Dermatologie für die gesamte Tumorforschung.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Albert RE (1976) Skin carcinogenesis. In: Andrade R, Gumport SL, Popkin GL, Rees TD (eds) Cancer of the skin. Saunders, Philadelphia London Toronto, p 111Google Scholar
  2. 2.
    Auerbach H (1961) Geographic variation in incidence of skin cancer in the United States. Public Health Rep 76: 345PubMedCrossRefGoogle Scholar
  3. 3.
    Bean SF, Foxley EG, Fusaro RM (1968) Palmar keratoses and international malignancy. A negative study. Arch Dermatol 97: 528PubMedCrossRefGoogle Scholar
  4. 4.
    Belisario IC (1959) Cancer of the skin. Butterworth, LondonGoogle Scholar
  5. 5.
    Berenblum I (1964) The two-stage mechanism of carcinogenesis as an analytical tool. In: Emmelot P, Muhlbock O (eds) Cellular control mechanisms and cancers. Elsevier, AmsterdamGoogle Scholar
  6. 6.
    Blum HF (1969) Quantitative aspects of cancer induction by ultraviolet light: including a revised model. In: Urbach F (ed) The biological effects of ultraviolet radiation. Pergamon Press, Oxford, p 543Google Scholar
  7. 7.
    Davis NC (1980) Queensland Melanom-Projekt. Ein Modell zur Früherkennung. In: Weidner F, Tonak J (Hrsg) Das maligne Melanom der Haut. perimed, Erlangen, p 51Google Scholar
  8. 7a.
    Dobson RL, Young MR, Pinto JS (1965) Palmar keratosis and cancer. Arch Dermatol 92: 553PubMedCrossRefGoogle Scholar
  9. 8.
    Doll R, Muir CS, Waterhouse JAH (1970) Cancer incidence in five continents, vol 2. Geneva UICC. Springer, Berlin Heidelberg New YorkGoogle Scholar
  10. 9.
    Duuren BL van, Sivak A, Goldschmidt BM, Katz C, Melchionne S (1970) Initiating activity of aromatic hydrocarbons in two-stage carcinogenesis. J Natl Cancer Inst 44: 1167PubMedGoogle Scholar
  11. 10.
    Duuren BL van (1969) Tumor promoting agents in two-stage carcinogenesis. Progr Exp Tumor Res 11: 31PubMedGoogle Scholar
  12. 11.
    Epstein JH, Roth HL (1968) Experimental ultraviolet light carcinogenesis: A study of croton oil promoting effects. J Invest Dermatol 50: 387PubMedGoogle Scholar
  13. 12.
    Farber E (1978) Experimental liver carcinogenesis: A perspective. In: Remmer H, Bolt HM, Bannasch P, Popper H (eds) Primary liver tumors. MTP Press, Lancaster, p 357Google Scholar
  14. 12a.
    Fierz U (1966) Katamnestische Untersuchungen über die Nebenwirkung der Therapie von Hautkrankheiten mit organischem Arsen. Arch Klin Exp Dermatol 227: 286PubMedGoogle Scholar
  15. 13.
    Frei JV, Stephens P (1968) The correlation of promotion of tumour growth and of induction of hyperplasia in epidermal two-stage carcinogenesis. Br J Cancer 22: 83PubMedCrossRefGoogle Scholar
  16. 14.
    Götz H (1976) Tar Keratosis. In: Andrade R, Gumport SL, Popkin GL, Rees TD (eds) Cancer of the skin. Saunders, Philadelphia London Toronto, pp 493Google Scholar
  17. 15.
    Gordon D, Silverstone H (1976) Worldwide epidemiology of premalignant and malignant cutaneous lesions. In: Andrade R, Gumport SL, Popkin GL, Rees TD (eds) Cancer of the skin. Saunders, Philadelphia London Toronto, pp 405Google Scholar
  18. 16.
    Graham JH, Helwig EB (1966) Cutaneous premalignant lesions. In: Montagna W, Dobson RL (eds) Advances in biology of skin. Vol VII, Carcinogenesis. Pergamon Press, OxfordGoogle Scholar
  19. 17.
    Graham JH, Mazzonti GR, Helwig EB (1961) Chemistry of Bowen’s disease: Relationship to arsenic. J Invest Dermatol 33: 317Google Scholar
  20. 18.
    zur Hausen H (1981) Virusinfektionen der Haut. Verh Dtsch Ges Pathol 65: 324PubMedGoogle Scholar
  21. 19.
    zur Hausen H (1980) The role of viruses in human tumors. Adv Cancer Res 33: 77–107PubMedCrossRefGoogle Scholar
  22. 20.
    Hornstein OP (1979) Präneoplasien der Epidermis. Verh Dtsch Ges Pathol 63: 132Google Scholar
  23. 21.
    Jung EG, Trachsel B (1970) Molekularbiologische Untersuchung zur Arsencarcinogenesis. Arch Klin Exp Dermatol 237: 819PubMedCrossRefGoogle Scholar
  24. 22.
    Knoth W (1966) Psoriasis vulgaris, Arsenbehandlung. Arch Klin Exp Dermatol 227: 228PubMedGoogle Scholar
  25. 23.
    Lawrence EA (1952) Carcinoma arising in the scars of thermal burns with special references to influence of age at burn on length of induction period. Surg Gynecol Obstet 95: 579PubMedGoogle Scholar
  26. 24.
    Lee PN, O Neill JA (1971) The effect both of time and dose applied on tumor incidence rate in benzopyrene skin painting experiments. Br J Cancer 25: 759PubMedCrossRefGoogle Scholar
  27. 25.
    Macdonald EJ, Bubendorf E (1964) Some epidemiologic aspects of skin cancer. In: Tumors of the skin. Seventh Annual Clinical Conference on Cancer, Houston, Texas, 1962. Year Book Medical Publishers, ChicagoGoogle Scholar
  28. 26.
    Meisels A, Roy M, Fortier M, Morin C, Casas-Cordero M, Shah KV, Turgeon H (1981) Human papillomavirus infection of the cervix. The atypical condyloma. Acta Cytol 25: 7PubMedGoogle Scholar
  29. 27.
    Miescher G (1943) Die Präkanzerose der Haut und der angrenzenden Schleimhäute. Schweiz Med Wochenschr 24: 1072Google Scholar
  30. 28.
    National Cancer Institute (1974) Report of third cancer incidence surveyGoogle Scholar
  31. 29.
    Orth G, Favre M, Breitburd F, Croissant O, Jablonska S, Obalek S, Jarzabek-Chorzelska M, Rzesa G (1980) Epidermodysplasia verruciformis, a model for the role of papilloma viruses in human cancer. In: Essex M, Todaro G, zur Hausen H (eds) Viruses in naturally occurring cancers. Harbor Lab Press, Cold Spring, vol 1: 259–282Google Scholar
  32. 30.
    Orth G, Jablonska S, Favre M, Croissant O, Jarzabek-Chorzelska M, Rzesa G (1978) Characterization of two new types of human papilloma viruses in lesions of epidermodysplasia verruciformis. Proc Nat Acad Sci U.S. 75: 1537Google Scholar
  33. 31.
    Petres J, Berger A (1972) Zum Einfluß anorganischen Arsens auf die DNS-Synthese menschlicher Lymphocyten in vitro. Arch Dermatol Res 242: 243Google Scholar
  34. 31a.
    Rabes HM (1979) Proliferative Vorgänge während der Frühstadien der malignen Transformation. Verh Dtsch Ges Pathol 63: 18Google Scholar
  35. 32.
    Rhodes EL (1970) Palmar-plantar seed keratoses and internal malignancy. Br J Dermatol 82: 361PubMedCrossRefGoogle Scholar
  36. 32a.
    Rohrbach R (1975) Zur Steuerung der Zellproliferation durch Chalone. Veröff Pathol 99: 1PubMedGoogle Scholar
  37. 33.
    Sanderson KV (1976) Arsenic and skin cancer. In: Andrade R, Gumport SL, Popkin GL, Rees TD (eds) Cancer of the skin. Saunders, Philadelphia London Toronto, pp 473Google Scholar
  38. 34.
    Silverstone H, Searle JHA (1970) The epidemiology of skin cancer in Queensland: the influence of phenotype and environment. Br J Cancer 24: 235PubMedCrossRefGoogle Scholar
  39. 35.
    Sweet RG (1964) Skin cancer in England. In: Blum HF, Urbach F (eds) Conference on sunlight and skin cancer. National Cancer Institute of Health, Bethesda, Maryland, p 69Google Scholar
  40. 36.
    ten Seldam REJ (1963) Skin cancer in Australia. In: Urbach F (ed) Conference of biology of cutaneous cancer. National Cancer Institute Monograph No 10, Washington, p 153Google Scholar
  41. 37.
    Thièrs H, Colomb D, Moulin G, Cohn L (1967) Le cancer cutané arsénical des viticulteurs du Beaujolais. Ann Dermatol Syphiligr (Paris) 94: 133Google Scholar
  42. 38.
    Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40: 453PubMedGoogle Scholar
  43. 39.
    Urbach F (1966) Ultraviolet radiation and its relationship to skin cancer in man. In: Montagna W (ed) Advances in biology of skin. Vol VII, Carcinogenesis. Pergamon Press, Oxford, p 581Google Scholar
  44. 40.
    Yeh S, How SW, Lin CS (1968) Arsenical cancer of the skin: histological study with special reference to Bowen’s disease (review). Cancer 21: 312PubMedCrossRefGoogle Scholar
  45. 41.
    Yeh S (1973) Skin cancer in chronic arsenicism. Hum Pathol 4: 469PubMedCrossRefGoogle Scholar
  46. 42.
    Zelickson AS, Prawer STE (1980) Bowenoid papulosis of the penis. Demonstration of intranuclear viral-like particles. Am J Dermatopathol 2: 305PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • O. P. Hornstein
    • 1
  1. 1.Univ.-HautklinikErlangenDeutschland

Personalised recommendations